KATHY NUNEZ: Open Payments
NPI 1740427095 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 97 payments from 8 companies in 2025. Trend: 2023 $759 · 2024 $1,032 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 49 | $243 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 18 | $239 |
| Novartis Pharmaceuticals Corporation | 17 | $213 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| Amgen Inc. | 4 | $71 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: LifeVest, LEQVIO, ELIQUIS, CAMZYOS, JARDIANCE, REPATHA, VERQUVO, ENTRESTO.
Industry payments across KS — which companies pay providers there.
